Sie sind auf Seite 1von 27

ARV di RSUD Cianjur

Dr Toton Suryotono SpPD

HASIL KEGIATAN CST


RSUD CIANJUR

02

04

05

06

07

08

09

10

11

CST
VCT
Test
HIV(+)
HIV (+)
Komul
atif
ART
PMTCT
Wafat

1
1
1

1
1
2

1
2
4

17
5
9

2
1

40 133 93 394 340


37 133 93 394 340
7 21 7 30 33
16 36 42 72 105
5

15

14

32

19

ARV
NRTI

NNRTI

PI

Nucleoside
Non Nucleoside
Protease Inhibitor
Reverse Transcriptase Reverse
Inhibitor
Transcriptase Inhibitor
ES:
Toksisitas Mitokondria

ES:
Hipersensitivitas

ES:
Gangguan Metabolik

ARV
NRTI

NNRTI

PI

AZT (Zidovudin)
3TC (Lamivudin)
FTC (Amcitabrin)
d4T (Stavudin)
TDF (Tenofovir)

NVP (Nevirapine)

LPV/r
(Lopinavir/Ritonavir)

EFZ (Efavirenz)

ARV

NVP

AZT
3TC
d4T

EFV

Anemia
Netropeni
a
Asidosis
laktat

ARV
Rash
Diare
Netropeni
a

NVP

AZT
3TC
Lipoatrof
Gangg
metabolik
Asidosis
laktat

d4T

EFV

Teratogenic
Depresi
Ansietas
Diare
Rash

ARV

NVP

AZT
3TC
d4T

EFV

ARV

NVP

AZT
3TC
d4T

EFV

ARV

NVP

AZT
3TC
d4T

EFV

ARV

AZT

NVP
3TC

d4T

EFV

ARV

AZT

NVP
3TC
FTC

d4T
TDF

EFV

When to start
All adolescents and adults
including pregnant women with
HIV infection and CD4 counts of
350 cells/mm3, should start
ART, regardless of the presence
or absence of clinical
symptoms.
Those with severe or advanced
clinical disease (WHO clinical
stage 3 or 4) should start ART
irrespective of their CD4 cell
count.

What to use in frst line


therapy
First-line therapy should
consist of an NNRTI + two
NRTIs, one of which should be
zidovudine (AZT) or tenofovir
(TDF).
Countries should take steps
to progressively reduce the
use of stavudine (d4T) in
frst-line regimens because of
its well-recognized toxicities

Co-trimoxazole
Co-trimoxazole prophylaxis is a simple,
well-tolerated and cost-effective
intervention for people living with HIV.
It should be implemented as an
integral component of the HIV chronic
care package and as a key element of
preantiretroviral therapy care.
Co-trimoxazole prophylaxis needs to
continue after antiretroviral therapy is
initiated until there is evidence of
immune recovery (see subsections 6.4
and 7.6).

Co-trimoxazole

Discontinuation of CTX

Discontinuation of CTX

Das könnte Ihnen auch gefallen